A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD
European Respiratory Journal - United Kingdom
doi 10.1183/09031936.00054213
Full Text
Open PDFAbstract
Available in full text
Date
October 10, 2013
Authors
Publisher
European Respiratory Society (ERS)